首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

酵素免疫分析法试验 (ELISA) 市场规模、份额和成长分析（按产品类型、应用、技术、最终用户和地区划分）—2026-2033 年产业预测

市场调查报告书

商品编码

1913990

酵素免疫分析法试验 (ELISA) 市场规模、份额和成长分析（按产品类型、应用、技术、最终用户和地区划分）—2026-2033 年产业预测

Enzyme-Linked Immunosorbent Assay Market Size, Share, and Growth Analysis, By Product Type (Kits, Reagents), By Application (Clinical Diagnostics, Research), By Technology, By End User, By Region -Industry Forecast 2026-2033.

出版日期: 2025年12月30日 | 出版商:

SkyQuest | 英文 192 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球酵素免疫分析法(ELISA) 市场规模预计在 2024 年达到 25.2 亿美元，从 2025 年的 26.5 亿美元成长到 2033 年的 39.5 亿美元，2026 年至 2033 年的复合年增长率为 5.1%。

全球酵素免疫分析法(ELISA) 市场正经历强劲成长，这主要得益于慢性病和感染疾病的增加、检测技术的进步以及在药物研发和食品安全领域应用范围的不断扩大。 ELISA 以其对生物样本中抗原和抗体的高精度定量分析而着称，使其成为疾病监测领域中及时诊断和治疗的关键工具。医疗保健模式从被动治疗向预防性治疗的转变进一步提升了 ELISA 在疾病早期检测方面的吸引力。此外，ELISA 在疫苗研发和品管中的关键作用也巩固了其在製药和研究领域的重要性。随着人工智慧、机器学习、物联网和区块链等技术的融合，ELISA 市场也不断发展，诊断效率和准确性也随之提升。

全球酵素免疫分析法(ELISA) 市场按产品类型、应用、技术、最终用户和地区进行细分。依产品类型划分，市场分为试剂盒、试剂和仪器。按应用划分，市场分为临床诊断、科研、兽医及其他。依技术划分，市场分为夹心 ELISA、间接 ELISA、竞争性 ELISA 和直接 ELISA。依最终用户划分，市场分为医院、诊断检查室、研究实验室及其他。按地区划分，市场分析涵盖北美、欧洲、亚太、拉丁美洲以及中东和非洲。

全球酵素免疫分析法试验 (ELISA) 市场驱动因素

日益严峻的健康挑战推动了对高效、扩充性且经济实惠的诊断工具的需求，这显着促进了酵素免疫分析法（ELISA）的应用。医疗机构、诊断检查室和研究实验室越来越多地将ELISA作为其标准诊断流程的重要组成部分，尤其是在需要高通量检测的环境中。此方法能够早期发现疾病进展，并实现对治疗效果的持续监测和评估，这对于慢性病和非传染性疾病的管理至关重要。因此，ELISA作为现代医学的关键工具，其应用日益广泛。

限制全球酵素免疫分析法（ELISA）市场的因素

全球酵素免疫分析法(ELISA) 市场面临许多限制因素，主要体现在其对专有抗体、酵素偶联物和专用试剂的依赖。这些产品需要高成本的生产流程、严格的检验和全面的品管措施。这些经济负担往往转嫁给最终用户，限制了资源匮乏地区用户的使用。此外，多重 ELISA 检测的复杂性也需要精细的最佳化来解决交叉反应、讯号干扰和试剂相容性等问题。这种复杂性为市场成长带来了挑战，尤其是在缺乏先进技术专长的地区，并总体上限制了 ELISA 技术的普及和应用。

全球酵素免疫分析法（ELISA）市场趋势

自动化和高通量平台的应用是全球酵素免疫分析法(ELISA) 市场的一大显着趋势。实验室和诊断中心正积极采用这些先进技术来提高营运效率。自动化 ELISA 分析仪能够实现从上样到结果报告的无缝流程，有效减少人为误差并缩短结果获取时间。这一趋势在药物研发等领域尤其明显，因为在这些领域，快速筛检大量样本的能力至关重要。随着对精准度和效率需求的不断增长，预计在这些创新解决方案的推动下，市场将持续成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Merck KGaA
Danaher Corporation
Abcam plc
Becton, Dickinson and Company
Agilent Technologies, Inc.
R&D Systems, Inc.
Enzo Life Sciences, Inc.
Ortho Clinical Diagnostics
BioLegend, Inc.
RayBiotech, Inc.
QIAGEN NV
GenScript Biotech Corporation

结论与建议

简介目录

Product Code: SQMIG35A3109

Global Enzyme-Linked Immunosorbent Assay Market size was valued at USD 2.52 Billion in 2024 and is poised to grow from USD 2.65 Billion in 2025 to USD 3.95 Billion by 2033, growing at a CAGR of 5.1% during the forecast period 2026-2033.

The global enzyme-linked immunosorbent assay (ELISA) market is witnessing robust growth driven by the increasing prevalence of chronic and infectious diseases, advancements in assay technology, and a broader range of applications in drug discovery and food safety. ELISA is renowned for its precision in quantifying antigens and antibodies in biological samples, making it a vital tool for timely diagnosis and treatment in the expanding realm of disease surveillance. The transition in healthcare from reactive to preventive approaches further enhances the appeal of ELISA for early disease detection. Moreover, its essential role in vaccine development and quality control solidifies its importance in pharmaceutical and research sectors. The market is also evolving with the integration of AI, machine learning, IoT, and blockchain technology, enhancing diagnostic efficiency and accuracy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enzyme-Linked Immunosorbent Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enzyme-Linked Immunosorbent Assay Market Segments Analysis

The global enzyme-linked immunosorbent assay market is segmented into product type, applications, technology, end users, and region. By product type, the market is categorized into kits, reagents, and instruments. Depending on application, it is classified into clinical diagnostics, research, veterinary, and others. Based on technology, it is divided into sandwich ELISA, indirect ELISA, competitive ELISA, and direct ELISA. Based on end user, it is categorized into hospitals, diagnostic laboratories, research institutes, and others. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Driver of the Global Enzyme-Linked Immunosorbent Assay Market

The rising prevalence of health challenges has led to a heightened demand for effective, scalable, and affordable diagnostic tools, significantly boosting the adoption of the Enzyme-Linked Immunosorbent Assay (ELISA). Healthcare facilities, diagnostic laboratories, and research institutions are turning to ELISA as an integral component of standard diagnostic processes, especially in scenarios that require high-throughput testing. This method facilitates early detection of disease progression and allows for ongoing monitoring and therapeutic evaluation, which are essential for managing both chronic and non-communicable diseases. Consequently, the reliance on ELISA continues to grow as a vital tool in modern healthcare.

Restraints in the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market faces significant constraints due to the reliance on proprietary antibodies, enzyme conjugates, and specialized reagents, all of which demand costly production processes, stringent validation, and comprehensive quality control measures. Such financial burdens frequently transfer to end users, restricting access in resource-limited settings. Additionally, the intricacies involved in multiplexing ELISA tests necessitate meticulous optimization to manage issues like cross-reactivity, signal interference, and reagent compatibility. This complexity poses challenges for market growth, particularly in environments lacking advanced technical expertise, thereby limiting the overall reach and adoption of ELISA technologies.

Market Trends of the Global Enzyme-Linked Immunosorbent Assay Market

The Global Enzyme-Linked Immunosorbent Assay (ELISA) market is experiencing a notable trend toward the adoption of automated and high-throughput platforms. Laboratories and diagnostic centers are increasingly integrating these advanced technologies to enhance operational efficiency. Automated ELISA analyzers facilitate seamless processes from plate loading to result reporting, effectively minimizing human error and accelerating turnaround times. This trend is particularly significant in sectors such as pharmaceutical research and vaccine development, where the capacity to rapidly screen large volumes of samples is critical. As the demand for precision and efficiency grows, the market is poised for sustained growth driven by these innovative solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Enzyme-Linked Immunosorbent Assay Market Size by Product Type & CAGR (2026-2033)

Market Overview
Kits
Reagents
Instruments

Global Enzyme-Linked Immunosorbent Assay Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical Diagnostics
Research
Veterinary
Others

Global Enzyme-Linked Immunosorbent Assay Market Size by Technology & CAGR (2026-2033)

Market Overview
Sandwich ELISA
Indirect ELISA
Competitive ELISA
Direct ELISA

Global Enzyme-Linked Immunosorbent Assay Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Research Institutes
Others

Global Enzyme-Linked Immunosorbent Assay Market Size & CAGR (2026-2033)

North America (Product Type, Application, Technology, End User)
- US
- Canada
Europe (Product Type, Application, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R&D Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Life Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLegend, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments